Advances in oral hormonal contraception.
Elstein
M
M
Department of Obstetrics and Gynaecology and Reproductive Health Care, St. Mary's Hospital, Manchester, UK.
Furniss
H A
HA
D001777:Blood Coagulation / Q000187:drug effects; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects* / Q000737:chemistry / Q000627:therapeutic use; D003279:Contraceptives, Oral, Sequential / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood; D011358:Product Surveillance, Postmarketing; D012307:Risk Factors
D003277:Contraceptives, Oral, Combined; D003279:Contraceptives, Oral, Sequential; D008055:Lipids